iSpecimen to effect 1-for-20 reverse stock split on Sep 13, 2024

iSpecimen Inc.

Reverse split ratio 1:20, effective 4:30 p.m. ET Sep 13; trading on split-adjusted basis begins Sep 16.
Board approved ratio on Aug 19, 2024, after stockholders authorized a 1:10 to 1:20 range on Jul 19.
Purpose: increase per-share price to attract institutional investors and maintain Nasdaq minimum bid listing.
All outstanding options, warrants, and RSUs proportionally adjusted; fractional shares rounded up.
Stock symbol remains ISPC on Nasdaq; new CUSIP 45032V207; Broadridge acting as exchange agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.